National Institute of Food and Drug Safety Evaluation
Scope
Date
~
-
Bio & Pharma
SK Biopharm holds sales meeting for marketing Cenobamate in US
On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...
Feb 16, 2023 (Gmt+09:00)
-
Food & Beverage
Hyundai Green Food breaks $1.5 billion in sales for first time in 2022
Hyundai Green Food Co., an affiliate of Hyundai Department Store Group, saw its main business unit of food surpass 2 trillion won ($1.5 billion) in ...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem builds S.Korea's first plant for clinical trials
LG Chem Ltd. has built South Korea’s first pharmaceutical plant dedicated to clinical trials, which the company expects to speed up its medici...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma, Sanofi to jointly market Plavix
GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...
Feb 13, 2023 (Gmt+09:00)
-
Real estate
Zigbang signs agreement with Saudi's National Housing Company
On Monday, South Korean proptech company Zigbang announced a partnership with Saudi Arabia's National Housing Company with the goal of digitalizing ...
Feb 13, 2023 (Gmt+09:00)
-
Electronics
LG provides electronics service training to Cambodian youths
LG Electronics Inc. said on Sunday that it is offering technology training to help talented Cambodian youths become more self-reliant.For four days ...
Feb 13, 2023 (Gmt+09:00)
-
ESG
Samsung Electro-Mechanics achieves highest ranking in CDP evaluation
Samsung Electro-Mechanics has achieved its highest ranking in the Carbon Disclosure Project (CDP) evaluation of climate change response. The company...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma wins permission from Singapore for Nabota
South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...
Feb 10, 2023 (Gmt+09:00)
-
IPOs
Oasis IPO draws tepid interest from institutional investors
South Korean grocery delivery platform Oasis Corp. saw lukewarm interest from domestic institutional investors during the Feb. 7-8 bookbuilding for ...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharmaceutical reports record-high revenue in 2022
South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...
Feb 09, 2023 (Gmt+09:00)
-
Banking & Finance
Kakao Bank announces record-high performance in 2022
South Korea's KakaoBank Corp. on Wednesday said its net profit last year reached a record-high 263.1 billion won ($208.6 million), up 28.9% from 202...
Feb 09, 2023 (Gmt+09:00)
-
Automobiles
Hyundai's IONIQ 5 named Best Electric Vehicle of 2023 in US
Cars.com, a US automobile evaluation website, named the Hyundai Motor Co.'s IONIQ 5 as the Best Electric Vehicle of 2023 on Tuesday. According to Hy...
Feb 08, 2023 (Gmt+09:00)
-
Foreign exchange
S.Korea to allow offshore investors to directly trade won
South Korea is set to allow offshore investors to directly trade the won and extend the operating hours of the local currency market from July next ...
Feb 07, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Boryung receives EU GMP certification
South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang, Synaffix ink deal to introduce ADC technology
Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...
Feb 06, 2023 (Gmt+09:00)
-
Sovereign bonds
S.Korean institutional investors inject more capital in MMFs
South Korean institutional investors, such as pension funds, mutual aids and corporates, are rushing to money market funds (MMFs) for short-term pro...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Banking & Finance
Industrial Bank of Korea goes all in with Eastern Europe push
Industrial Bank of Korea (IBK) will open an office in Poland in the first half of this year, with analysts saying the bank's president Kim Seong-tae...
Feb 06, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
S.Korea's NIA to extend IT cooperation project with Kazakhstan
South Korea's state-run research institute National Information Society Agency (NIA) said on Friday that it had signed an agreement with Kazakhstan'...
Feb 03, 2023 (Gmt+09:00)
-
ESG
SK Bioscience climbs two notches in ESG evaluation, receives BBB rating
SK Bioscience Co., a biopharmaceutical arm of South Korea's SK Group, announced it has received a BBB rating in its latest environmental, social, an...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma submits clinical trial plan in Australia
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, has applied to the Australian clini...
Feb 03, 2023 (Gmt+09:00)
-
Airlines
KAL introduces self-service bag drop for domestic flights
South Korea's flagship carrier Korean Air Lines Co. is the first airline in the country to adopt self-service bag drop on domestic flights.The compa...
Feb 03, 2023 (Gmt+09:00)
-
Food & Beverage
S.Korea's Woowa Brothers launches professional service robot affiliate
Woowa Brothers, the parent company of South Korea's food delivery app Baedal Minjok, on Wednesday spun off its professional service robot unit into ...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's InCerebro to leverage AI to identify drug candidates
South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...
Feb 01, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea's fisheries ministry to transfer tech on Napoleon fish to SE Asia
South Korea's Ministry of Oceans and Fisheries will transfer technology to Indonesia on farming the tropical Napoleon fish and reduce sea pollution ...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Banking & Finance
Korea's credit card approval volume hit all-time high last year
The annual card approval amount in South Korea exceeded 1,000 trillion won ($811.4 billion) for the first time ever. This is largely because of "ret...
Feb 01, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
KISA launches ASEAN Cyber Shield project for strengthening cyber security
The Korea Internet & Security Agency (KISA) on Monday has announced the launch of the "ASEAN Cyber Shield" project, a major international cooper...
Jan 31, 2023 (Gmt+09:00)
Latest News
- 1 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 2 AI startup MarqVision raises $16.5 mn to close Series A
- 3 Taihan Cable wins $630 mn power grid project in Singapore
- 4 Korean startup scene is gloomy, say 2 out of 5 startup CEOs
- 5 MBK ups stakes for Korea Zinc to match buyback offer